1. Home
  2. NRO vs GBIO Comparison

NRO vs GBIO Comparison

Compare NRO & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRO
  • GBIO
  • Stock Information
  • Founded
  • NRO 2003
  • GBIO 2016
  • Country
  • NRO United States
  • GBIO United States
  • Employees
  • NRO N/A
  • GBIO N/A
  • Industry
  • NRO Finance/Investors Services
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRO Finance
  • GBIO Health Care
  • Exchange
  • NRO Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • NRO 187.8M
  • GBIO 64.8M
  • IPO Year
  • NRO N/A
  • GBIO 2020
  • Fundamental
  • Price
  • NRO $3.50
  • GBIO $0.88
  • Analyst Decision
  • NRO
  • GBIO Strong Buy
  • Analyst Count
  • NRO 0
  • GBIO 2
  • Target Price
  • NRO N/A
  • GBIO $6.50
  • AVG Volume (30 Days)
  • NRO 239.4K
  • GBIO 581.0K
  • Earning Date
  • NRO 01-01-0001
  • GBIO 03-05-2025
  • Dividend Yield
  • NRO 11.41%
  • GBIO N/A
  • EPS Growth
  • NRO N/A
  • GBIO N/A
  • EPS
  • NRO N/A
  • GBIO N/A
  • Revenue
  • NRO N/A
  • GBIO $18,582,000.00
  • Revenue This Year
  • NRO N/A
  • GBIO $212.74
  • Revenue Next Year
  • NRO N/A
  • GBIO N/A
  • P/E Ratio
  • NRO N/A
  • GBIO N/A
  • Revenue Growth
  • NRO N/A
  • GBIO 514.08
  • 52 Week Low
  • NRO $2.51
  • GBIO $0.75
  • 52 Week High
  • NRO $3.45
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • NRO 42.49
  • GBIO 28.66
  • Support Level
  • NRO $3.52
  • GBIO $0.85
  • Resistance Level
  • NRO $3.62
  • GBIO $1.01
  • Average True Range (ATR)
  • NRO 0.08
  • GBIO 0.12
  • MACD
  • NRO 0.01
  • GBIO 0.00
  • Stochastic Oscillator
  • NRO 40.00
  • GBIO 7.50

About NRO Neuberger Berman Real Estate Securities Income Fund Inc.

NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. The fund invests in sectors, such as apartments, Data Centers, Infrastructure REITs, Manufactured Homes, Office, Regional Malls and others.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: